Literature DB >> 2678551

Ophthalmologic manifestations of Alzheimer's disease.

B Katz1, S Rimmer.   

Abstract

Alzheimer's disease is a progressive neurologic disorder which may present with visual disturbance before the diagnosis is clearly established. Central acuity and visual field are initially normal. Alzheimer patients may show anomalies of color vision, spatial contrast sensitivity, susceptibility to visual masks, fundus examination, ocular motility, higher cortical visual function, visual evoked potential, and pattern electroretinogram. Pathologic analysis has shown abnormalities at all levels of the visual axis from retinal ganglion cell to associative visual cortex. Correlations between the visual abnormalities of Alzheimer's disease and corresponding neuroanatomic substrates are discussed.

Entities:  

Mesh:

Year:  1989        PMID: 2678551     DOI: 10.1016/0039-6257(89)90127-6

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  59 in total

1.  Ocular changes in TgF344-AD rat model of Alzheimer's disease.

Authors:  Yuchun Tsai; Bin Lu; Alexander V Ljubimov; Sergey Girman; Fred N Ross-Cisneros; Alfredo A Sadun; Clive N Svendsen; Robert M Cohen; Shaomei Wang
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-01-29       Impact factor: 4.799

2.  Visual discrimination predicts naming and semantic association accuracy in Alzheimer disease.

Authors:  Stacy M Harnish; Jean Neils-Strunjas; James Eliassen; Jamie Reilly; Marcus Meinzer; John Greer Clark; Jane Joseph
Journal:  Cogn Behav Neurol       Date:  2010-12       Impact factor: 1.600

3.  Beta-amyloid deposition and functional impairment in the retina of the APPswe/PS1DeltaE9 transgenic mouse model of Alzheimer's disease.

Authors:  Sylvia E Perez; Stephen Lumayag; Beatrix Kovacs; Elliott J Mufson; Shunbin Xu
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-09-12       Impact factor: 4.799

Review 4.  Computational neuroimaging and population receptive fields.

Authors:  Brian A Wandell; Jonathan Winawer
Journal:  Trends Cogn Sci       Date:  2015-04-04       Impact factor: 20.229

5.  Posterior cortical atrophy in Alzheimer's disease: analysis of a new case and re-evaluation of a historical report.

Authors:  P R Hof; N Archin; A P Osmand; J H Dougherty; C Wells; C Bouras; J H Morrison
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

6.  Resveratrol Protects Optic Nerve Head Astrocytes from Oxidative Stress-Induced Cell Death by Preventing Caspase-3 Activation, Tau Dephosphorylation at Ser422 and Formation of Misfolded Protein Aggregates.

Authors:  John C Means; Adam A Lopez; Peter Koulen
Journal:  Cell Mol Neurobiol       Date:  2020-01-09       Impact factor: 5.046

7.  Amyloid-peptide vaccinations reduce {beta}-amyloid plaques but exacerbate vascular deposition and inflammation in the retina of Alzheimer's transgenic mice.

Authors:  Bingqian Liu; Suhail Rasool; Zhikuan Yang; Charles G Glabe; Steven S Schreiber; Jian Ge; Zhiqun Tan
Journal:  Am J Pathol       Date:  2009-10-15       Impact factor: 4.307

8.  Receptor for advanced glycation end products is upregulated in optic neuropathy of Alzheimer's disease.

Authors:  Michelle Y Wang; Fred N Ross-Cisneros; Divya Aggarwal; Chiao-Ying Liang; Alfredo A Sadun
Journal:  Acta Neuropathol       Date:  2009-03-11       Impact factor: 17.088

9.  Ophthalmologic screening in 25 consecutive geriatric psychiatric inpatient admissions.

Authors:  Stephen B Billick; Amir Garakani
Journal:  Psychiatr Q       Date:  2014-03

10.  Pupil response biomarkers distinguish amyloid precursor protein mutation carriers from non-carriers.

Authors:  Shaun M Frost; Yogesan Kanagasingam; Hamid R Sohrabi; Kevin Taddei; Randall Bateman; John Morris; Tammie Benzinger; Alison Goate; Colin L Masters; Ralph N Martins
Journal:  Curr Alzheimer Res       Date:  2013-10       Impact factor: 3.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.